Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.


Player Avatar rstruyk (21.30) Submitted: 12/18/2012 3:59:14 PM : Outperform Start Price: $97.29 ALXN Score: -1.98

everyone loves this stock. It wasn't just added to the S&P 500 for no reason. Earnings, Sales, ROE are all exceptional. Created a niche market for rare diseases and management will continue to outperform expectations.

Featured Broker Partners